| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$2,167,872 ) (Continued on the next page) |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH127308 | Adaptation and assessment of a common element treatment protocol designed to improve mental health in forcibly displaced populations | 000 | 4 | NIH | 2/13/2025 | $184,034 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an inherent bias in neuroprognostication: A collaboration between the US and Brazil to reduce the impact of Self-fulfilling Prophecy in cardiac ARrEst (SPARE) | 000 | 2 | NIH | 11/26/2024 | $532,674 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA061939 | Community-Engaged Development of a Peer Breastfeeding Support Intervention for Mothers with Opioid Use Disorder | 000 | 1 | NIH | 1/23/2025 | $193,550 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P30HS029752 | Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) | 000 | 2 | AHRQ | 11/18/2024 | $978,045 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL165097 | From Hypertensive Pregnancy to Heart Health: Understanding and Addressing Multi-Level Barriers to Cardiovascular Health after Hypertensive Disorders of Pregnancy | 000 | 2 | NIH | 1/18/2025 | $92,614 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL165097 | From Hypertensive Pregnancy to Heart Health: Understanding and Addressing Multi-Level Barriers to Cardiovascular Health after Hypertensive Disorders of Pregnancy | 000 | 2 | NIH | 1/18/2025 | $88,838 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL168098 | Identification of a mechanosensor in juxtaglomerular cells for the regulation of renin synthesis and secretion | 000 | 2 | NIH | 12/24/2024 | $640,376 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 000 | 2 | NIH | 12/19/2024 | $854,975 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 000 | 9 | NIH | 11/22/2024 | $370,064 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 000 | 5 | NIH | 3/24/2025 | $216,099 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 000 | 4 | NIH | 3/21/2025 | $372,536 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH128639 | Medicaid Accountable Care Organizations (ACO) and Quality of Care for Adults with Serious Mental Illness (SMI) | 000 | 4 | NIH | 3/13/2025 | $189,432 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21CA286402 | Delineating the myeloid-centric immunosuppressive crosstalk as targets for prognosis and therapy in neuroendocrine tumors | 000 | 2 | NIH | 1/8/2025 | $222,077 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU58DP007538 | CHAMPS National | 01 | 2 | CDC | 12/18/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 000 | 2 | NIH | 3/17/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21AI178913 | Understanding the effects of cross-sex hormone therapy on vaginal mucosal immunity | 000 | 2 | NIH | 3/13/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H1224845 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 12 | HRSA | 1/15/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9746074 | Special Projects of National Significance - Demonstration/Implementation Sites | 02 | 3 | HRSA | 12/23/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 01 | 3 | DHHS/OS | 2/7/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 000 | 4 | SAMHSA | 12/16/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 001 | 4 | SAMHSA | 1/23/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R61DA062217 | A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk | 000 | 1 | NIH | 12/18/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 01 | 2 | CDC | 12/26/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34MH137223 | Developing measures to improve access to integrated mental health care services in under-resourced global settings | 000 | 1 | NIH | 11/4/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9E53185 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 01 | 1 | HRSA | 10/16/2024 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Assessing the burden of dementia in transgender populations | 001 | 4 | NIH | 3/25/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Assessing the burden of dementia in transgender populations | 000 | 4 | NIH | 3/25/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UT953486 | Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention | 02 | 1 | HRSA | 3/22/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21DA062256 | The Youth Empowerment Study (YES) | 000 | 1 | NIH | 2/25/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 3 | NIH | 3/28/2025 | $0 |
| | 2025 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA033211 | Advancing Clinical Research Training within Addiction Residency Programs | 001 | 11 | NIH | 2/13/2025 | $212,350 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21TW012165 | Simulator-Based simplified Focused Cardiac Ultrasound (sFoCUS) Training in Haiti | 000 | 2 | NIH | 3/12/2025 | $0 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UH3AT010621 | Group-Based Mindfulness for Patients with Chronic Low Back Pain in the Primary Care | 000 | 5 | NIH | 3/13/2025 | $0 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA046527 | Researching Effective Strategies to Prevent Opioid Death (RESPOND) | 002 | 6 | NIH | 12/6/2024 | $160,686 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention For Low Income Public Housing Residents - Diversity Supplement | 001 | 3 | NIH | 12/20/2024 | -$657,973 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 01 | 3 | DHHS/OS | 2/7/2025 | $0 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32DK007201 | Metabolism, Endocrinology, and Obesity Training Grant | 003 | 46 | NIH | 11/19/2024 | -$424,690 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CE003357 | CE21-002, Integrating responses to stimulant overdose among post-overdose programs | 02 | 3 | CDC | 1/7/2025 | $0 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 01 | 2 | CDC | 12/26/2024 | $0 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers Among Public Housing Residents | 001 | 4 | NIH | 11/1/2024 | -$179,376 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UM1DA049412 | MassHEAL - Reducing overdose deaths by 40% (2019-2023) | 000 | 4 | NIH | 10/1/2024 | -$4,589,462 |
| | 2025 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K24AI145661 | HIV-1 mucosal transmission and persistence | 000 | 5 | NIH | 3/10/2025 | -$8 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA046527 | Researching Effective Strategies to Prevent Opioid Death (RESPOND) | 001 | 5 | NIH | 12/6/2024 | -$160,686 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH118478 | Developing a Pediatrics-based Social Needs Intervention to Reduce Disparities in ADHD Outcomes for Low-income Children | 001 | 4 | NIH | 1/14/2025 | -$1 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention For Low Income Public Housing Residents - Diversity Supplement | 000 | 2 | NIH | 12/20/2024 | -$38,157 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 000 | 2 | NIH | 1/23/2025 | -$87,112 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL140133 | Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based intervention | 000 | 4 | NIH | 12/16/2024 | -$84,115 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32DK007201 | Metabolism, Endocrinology, and Obesity Training Grant | 002 | 45 | NIH | 11/19/2024 | -$308,170 |
| | 2025 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CE003357 | CE21-002, Integrating responses to stimulant overdose among post-overdose programs | 02 | 3 | CDC | 1/7/2025 | $0 |
|
